Physician profile
Keyvan Abtin
NPI 1871503862
$2,502.80
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,262 · 2020: $185 · 2022: $55.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,491.45 | 2019 | |
| Zimmer Biomet Holdings, INC. | $356.91 | 2019 | |
| Integra Lifesciences Corporation | $170.68 | 2019 | |
| Si-Bone, INC. | $114.08 | 2020 | |
| Aesculap Implant Systems, LLC | $82.48 | 2019 | |
| Life Spine, INC. | $73.00 | 2019 | |
| Livanova USA, INC. | $68.38 | 2019-2020 | |
| Intrinsic Therapeutics | $55.66 | 2020 | |
| Cerapedics INC. | $55.20 | 2022 | |
| Depuy Synthes Sales INC. | $34.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyvan Abtin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.